Bullish option flow detected in Cytokinetics with 1,300 calls trading, 1.4x expected, and implied vol increasing almost 3 points to 114.20%. Jan-24 45 calls and Dec-23 40 calls are the most active options, with total volume in those strikes near 1,200 contracts. The Put/Call Ratio is 0.02. Earnings are expected on February 28th.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CYTK:
- Needham healthcare analysts hold an analyst/industry conference call
- Truist biotech analyst to hold an analyst/industry conference call
- Goldman Sachs Says These 2 Healthcare Stocks Look Attractive — Here’s What Makes Them Each a ‘Buy’ Right Now
- JPMorgan opens ‘Positive Catalyst Watch’ on Cytokinetics into data
- Tesla initiated, Kellanova upgraded: Wall Street’s top analyst calls
